Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Litigation In Brief

This article was originally published in The Gray Sheet

Executive Summary

J&J/Medtronic stent litigation: Supreme Court declines to review ruling awarding Johnson & Johnson/Cordis $271 mil. for infringement of stent patents, including those related to its Palmaz-Schatz('762), denying a writ of certiorari in the case. The U.S. Court of Appeals for the Federal Circuit had denied a rehearing in September 2003 after siding with J&J last August and remanded the case back to its original Wilmington, Del. district court (1"The Gray Sheet" Oct. 6, 2003, In Brief). Medtronic notes that the stents at issue are obsolete...

You may also be interested in...



Mentor v. American Medical Systems

Urology firms settle alleged infringement of Mentor's '211 trans-obturator patent, related to the firm's ObTape and AMS' Monarc subfascial hammocks for stress urinary incontinence in women. The deal includes a one-time payment by AMS of $2.5 mil. to Mentor and a non-exclusive cross-licensing agreement. Related lawsuits will be dismissed (1"The Gray Sheet" March 31, 2004, p. 13)...

Mentor v. American Medical Systems

Urology firms settle alleged infringement of Mentor's '211 trans-obturator patent, related to the firm's ObTape and AMS' Monarc subfascial hammocks for stress urinary incontinence in women. The deal includes a one-time payment by AMS of $2.5 mil. to Mentor and a non-exclusive cross-licensing agreement. Related lawsuits will be dismissed (1"The Gray Sheet" March 31, 2004, p. 13)...

Mentor Breast Implant Sales Up 23% Despite Silicone Approval Delay

Mentor's silicone gel breast implant approval will be delayed at least until 2005 due to the political controversy surrounding the device, according to Peter Nicholson, VP-strategic planning and investor relations

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019833

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel